Updated Genomic Epidemiologic Description of Candida (Candidozyma) auris, United States
May 13, 2026ESCMID-EFISG Study Group Research Grants
June 18, 2026Dear members of HSoMM,
We attach the links for two seminars from the ESCMID Fungal Infection Study Group (EFISG), with free attendance (after registration).
2 July 2026 | 16:00 CET | Non-IV Amphotericin B Evidence: Applications and Pharmacological Rationale, EFISG in collaboration with the EHA Scientific Working Group on Infections in Hematology
🔗 Registration: ehaweb-org.zoom.us/meeting/register/CLWsa-3ISK6DRngQz-xVJA#/registration
🎯 Topics include:
• Localized amphotericin B delivery protocols and non-IV administration routes
• Pharmacological formulations and toxicity considerations
• Deoxycholate versus lipid formulations
• Clinical outcomes and safety profiles in refractory infections
17 November 2026 | 15:00 CET | Difficult and Curious Fungal Diseases Clinical Cases
🔗 Registration: us06web.zoom.us/webinar/register/WN_SynZOZ9CSc-Em1pnGaB69Q#/registration
🔥 Topics include:
• Atypical fungal infections during BTKi therapy
• Granulocyte transfusion in Saprochaete clavata infection
• Stem cell transplantation in disseminated fusariosis
• Endemic mycoses and lung cancer
• Complex fungal diseases in immunosuppressed patients
Sincerely,
the Board of Directors of HSoMM
